Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-070902
Filing Date
2025-05-14
Accepted
2025-05-14 07:10:23
Documents
71
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q clym-20250331.htm   iXBRL 10-Q 2314752
2 EX-10.4 clym-ex10_4.htm EX-10.4 197858
3 EX-10.5 clym-ex10_5.htm EX-10.5 167781
4 EX-10.6 clym-ex10_6.htm EX-10.6 21573
5 EX-31.1 clym-ex31_1.htm EX-31.1 17739
6 EX-31.2 clym-ex31_2.htm EX-31.2 17160
7 EX-32.1 clym-ex32_1.htm EX-32.1 10783
8 EX-32.2 clym-ex32_2.htm EX-32.2 10206
9 GRAPHIC img209458866_0.jpg GRAPHIC 171759
  Complete submission text file 0000950170-25-070902.txt   9886080

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT clym-20250331.xsd EX-101.SCH 1276064
73 EXTRACTED XBRL INSTANCE DOCUMENT clym-20250331_htm.xml XML 1611891
Mailing Address 20 WILLIAM STREET SUITE 145 WELLESLEY HILLS MA 02481
Business Address 20 WILLIAM STREET SUITE 145 WELLESLEY HILLS MA 02481 1-866-857-2596
Climb Bio, Inc. (Filer) CIK: 0001768446 (see all company filings)

EIN.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40708 | Film No.: 25942622
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)